Abstract
PS-134-Oral treatment with PBI-4547 promotes beta-oxidation and energy expenditure, and reverses liver damage and white adipose tissue fibrosis in high-fat diet and ob/ob mouse models of NAFLD.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have